The pivotal role of fibrocytes and mast cells in mediating fibrotic reactions to biomaterials

Biomaterials

Volumn 32, Issue 33, 2011, Pages 8394-8403

  Thevenot, Paul T ^a,b   Baker, David W ^a,b   Weng, Hong ^b   Sun, Man Wu ^a,b   Tang, Liping ^a,b  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b University of Texas at Arlington   (United States)

Author keywords

Cell activation; Fibroblast; Fibrosis; Foreign body response; Inflammation; Mast cell

Indexed keywords

CELL ACTIVATION; FIBROSIS; FOREIGN BODY RESPONSE; INFLAMMATION; MAST CELLS;

BYPRODUCTS; CELL CULTURE; COLLAGEN; FIBROBLASTS; MAMMALS; TISSUE;

IMPLANTS (SURGICAL);

CD45 ANTIGEN; COLLAGEN TYPE 1; COMPOUND 48-80; CROMOGLYCATE DISODIUM; POLYGLACTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL MIGRATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; FIBROCYTE; FIBROSIS; MAST CELL; MOUSE; MYOFIBROBLAST; NONHUMAN; PRIORITY JOURNAL; WILD TYPE;

ANIMALS; BIOCOMPATIBLE MATERIALS; FEMALE; FIBROBLASTS; FIBROSIS; MALE; MAST CELLS; MICE; MICE, INBRED C57BL;

MUS;

EID: 80052967617     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.07.084     Document Type: Article

References (72)

1. Tang L., Eaton J.W. Natural responses to unnatural materials: a molecular mechanism for foreign body reactions. Mol Med 1999, 5(6):351-358.
2. Tang L., Eaton J.W. Inflammatory responses to biomaterials. Am J Clin Pathol 1995, 103(4):466-471.
3. Chegini N. Peritoneal molecular environment, adhesion formation and clinical implication. Front Biosci 2002, 7:e91-115.
4. Backovic A., Wolfram D. Silicone mammary implants-can we turn back the time?. Exp Gerontol 2007, 42(8):713-718.
5. Patil S.D., Papadimitrakopoulos F., Burgess D.J. Dexamethasone-loaded poly(lactic-co-glycolic) acid microspheres/poly(vinyl alcohol) hydrogel composite coatings for inflammation control. Diabetes Technol Ther 2004, 6(6):887-897.
6. Giurgiutiu V., Friedman H., Bender J., Borg T., Yost M., Newcomb W., et al. Electromechanical impedance sensor for in vivo monitoring the body reaction to implants. J Invest Surg 2004, 17(5):257-270.
7. Sargeant A., Goswami T. Pathophysiological aspects of hip implants. J Surg Orthop Adv 2006, 15(2):111-112.
8. Adams W.P., Haydon M.S., Raniere J., Trott S., Marques M., Feliciano M., et al. A rabbit model for capsular contracture: development and clinical implications. Plast Reconstr Surg 2006, 117(4):1214-1219.
9. Cutroneo K.R., White S.L., Chiu J.F., Ehrlich H.P. Tissue fibrosis and carcinogenesis: divergent or successive pathways dictate multiple molecular therapeutic targets for oligo decoy therapies. J Cell Biochem 2006, 97(6):1161-1174.
10. Prantl L., Schreml S., Fichtner-Feigl S., Poppl N., Eisenmann-Klein M., Schwarze H., et al. Clinical and morphological conditions in capsular contracture formed around silicone breast implants. Plast Reconstr Surg 2007, 120(1):275-284.
11. Seymour J.P., Kipke D.R. Neural probe design for reduced tissue encapsulation in CNS. Biomaterials 2007, 28(25):3594-3607.
12. Shirai K., Saika S., Okada Y., Oda S., Ohnishi Y. Histology and immunohistochemistry of fibrous posterior capsule opacification in an infant. J Cataract Refract Surg 2004, 30(2):523-526.
13. Polikov V.S., Tresco P.A., Reichert W.M. Response of brain tissue to chronically implanted neural electrodes. J Neurosci Methods 2005, 148(1):1-18.
14. Egozi E.I., Ferreira A.M., Burns A.L., Gamelli R.L., Dipietro L.A. Mast cells modulate the inflammatory but not the proliferative response in healing wounds. Wound Repair Regen 2003, 11(1):46-54.
15. Soder B.L., Propst J.T., Brooks T.M., Goodwin R.L., Friedman H.I., Yost M.J., et al. The connexin43 carboxyl-terminal peptide ACT1 modulates the biological response to silicone implants. Plast Reconstr Surg 2009, 123(5):1440-1451.
16. Chan A., Filer A., Parsonage G., Kollnberger S., Gundle R., Buckley C.D., et al. Mediation of the proinflammatory cytokine response in rheumatoid arthritis and spondylarthritis by interactions between fibroblast-like synoviocytes and natural killer cells. Arthritis Rheum 2008, 58(3):707-717.
17. Darby I.A., Hewitson T.D. Fibroblast differentiation in wound healing and fibrosis. Int Rev Cytol 2007, 257:143-179.
18. Chang D.T., Jones J.A., Meyerson H., Colton E., Kwon I.K., Matsuda T., et al. Lymphocyte/macrophage interactions: biomaterial surface-dependent cytokine, chemokine, and matrix protein production. J Biomed Mater Res A 2008, 87(3):676-687.
19. Luttikhuizen D.T., Dankers P.Y., Harmsen M.C., van Luyn M.J. Material dependent differences in inflammatory gene expression by giant cells during the foreign body reaction. J Biomed Mater Res A 2007, 83(3):879-886.
20. Tang L., Hu W. Molecular determinants of biocompatibility. Expert Rev Med Devices 2005, 2(4):493-500.
21. Mendes J.B., Campos P.P., Ferreira M.A., Bakhle Y.S., Andrade S.P. Host response to sponge implants differs between subcutaneous and intraperitoneal sites in mice. J Biomed Mater Res B Appl Biomater 2007, 83(2):408-415.
22. Patil S.D., Papadmitrakopoulos F., Burgess D.J. Concurrent delivery of dexamethasone and VEGF for localized inflammation control and angiogenesis. J Control Release 2007, 117(1):68-79.
23. Butler K.R., Benghuzzi H.A. Immunohistochemical detection of cytokine expression in tissue-implant response associated with TCP bioceramic implants loaded with steroid hormones. Biomed Sci Instrum 2003, 39:541-546.
24. Butler K.R., Benghuzzi H.A. Morphometric analysis of the hormonal effect on tissue-implant response associated with TCP bioceramic implants. Biomed Sci Instrum 2003, 39:535-540.
25. Hickey T., Kreutzer D., Burgess D.J., Moussy F. In vivo evaluation of a dexamethasone/PLGA microsphere system designed to suppress the inflammatory tissue response to implantable medical devices. J Biomed Mater Res 2002, 61(2):180-187.
26. Trivedi A., Olivas A.D., Noble-Haeusslein L.J. Inflammation and spinal cord Injury: infiltrating leukocytes as determinants of injury and repair processes. Clin Neurosci Res 2006, 6(5):283-292.
27. Braiman-Wiksman L., Solomonik I., Spira R., Tennenbaum T. Novel insights into wound healing sequence of events. Toxicol Pathol 2007, 35(6):767-779.
28. Lumelsky N.L. Commentary: engineering of tissue healing and regeneration. Tissue Eng 2007, 13(7):1393-1398.
29. Oberyszyn T.M. Inflammation and wound healing. Front Biosci 2007, 12:2993-2999.
30. Broughton G., Janis J.E., Attinger C.E. The basic science of wound healing. Plast Reconstr Surg 2006, 117(7 Suppl). 12S-34S.
31. Henry G., Garner W.L. Inflammatory mediators in wound healing. Surg Clin North Am 2003, 83(3):483-507.
32. Quan T.E., Cowper S., Wu S.-P., Bockenstedt L.K., Bucala R. Circulating fibrocytes: collagen-secreting cells of the peripheral blood. Int J Biochem Cell Biol 2004, 36(4):598-606.
33. El-Asrar A.M.A., Struyf S., Van Damme J., Geboes K. Circulating fibrocytes contribute to the myofibroblast population in proliferative vitreoretinopathy epiretinal membranes. Br J Ophthalmol 2008, 92(5):699-704.
34. Mori L., Bellini A., Stacey M.A., Schmidt M., Mattoli S. Fibrocytes contribute to the myofibroblast population in wounded skin and originate from the bone marrow. Exp Cell Res 2005, 304(1):81-90.
35. Quan T.E., Cowper S.E., Bucala R. The role of circulating fibrocytes in fibrosis. Curr Rheumatol Rep 2006, 8(2):145-150.
36. Schmidt M., Sun G., Stacey M.A., Mori L., Mattoli S. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J Immunol 2003, 171(1):380-389.
37. Strieter R.M., Keeley E.C., Hughes M.A., Burdick M.D., Mehrad B. The role of circulating mesenchymal progenitor cells (fibrocytes) in the pathogenesis of pulmonary fibrosis. J Leukoc Biol 2009, 86(5):1111-1118.
38. Phillips R.J., Burdick M.D., Hong K., Lutz M.A., Murray L.A., Xue Y.Y., et al. Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. J Clin Invest 2004, 114(3):438-446.
39. Zdolsek J., Eaton J.W., Tang L. Histamine release and fibrinogen adsorption mediate acute inflammatory responses to biomaterial implants in humans. J Transl Med 2007, 5:31.
40. Tang L., Jennings T.A., Eaton J.W. Mast cells mediate acute inflammatory responses to implanted biomaterials. Proc Natl Acad Sci U S A 1998, 95(15):8841-8846.
41. Brightling C.E., Bradding P., Pavord I.D., Wardlaw A.J. New insights into the role of the mast cell in asthma. Clin Exp Allergy 2003, 33(5):550-556.
42. Tcacencu I., Wendel M. Collagen-hydroxyapatite composite enhances regeneration of calvaria bone defects in young rats but postpones the regeneration of calvaria bone in aged rats. J Mater Sci Mater Med 2008, 19(5):2015-2021.
43. Orenstein S.B., Saberski E.R., Klueh U., Kreutzer D.L., Novitsky Y.W. Effects of mast cell modulation on early host response to implanted synthetic meshes. Hernia 2010, 14(5):511-516.
44. Thevenot P., Nair A., Dey J., Yang J., Tang L. Method to analyze three-dimensional cell distribution and infiltration in degradable scaffolds. Tissue Eng Part C Methods 2008, 14(4):319-331.
45. Dumont N., Lepage K., Cote C.H., Frenette J. Mast cells can modulate leukocyte accumulation and skeletal muscle function following hindlimb unloading. J Appl Physiol 2007, 103(1):97-104.
46. Bytautiene E., Vedernikov Y.P., Saade G.R., Romero R., Garfield R.E. The effect of a mast cell degranulating agent on vascular resistance in the human placental vascular bed and on the tone of isolated placental vessels. Reprod Sci 2008, 15(1):26-32.
47. Thevenot P.T., Nair A.M., Shen J., Lotfi P., Ko C.-Y., Tang L. The effect of incorporation of SDF-1a into PLGA scaffolds on stem cell recruitment and the inflammatory response. Biomaterials 2010, 31:3997-4008.
48. Bellini A., Mattoli S. The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest 2007, 87(9):858-870.
49. Wynn T.A. Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases. J Clin Invest 2007, 117(3):524-529.
50. Bucala R., Spiegel L.A., Chesney J., Hogan M., Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994, 1(1):71-81.
51. Baker D.W., Liu X., Weng H., Luo C., Tang L. Fibroblast/Fibrocyte: surface interaction dictates tissue reactions to micropillar implants. Biomacromolecules 2011, 12(4):997-1005.
52. Wada T., Sakai N., Matsushima K., Kaneko S. Fibrocytes: a new insight into kidney fibrosis. Kidney Int 2007, 72(3):269-273.
53. Keeley E.C., Mehrad B., Strieter R.M. Fibrocytes: bringing new insights into mechanisms of inflammation and fibrosis. Int J Biochem Cell Biol 2010, 42(4):535-542.
54. Moore B.B., Kolodsick J.E., Thannickal V.J., Cooke K., Moore T.A., Hogaboam C., et al. CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. Am J Pathol 2005, 166(3):675-684.
55. Chesney J., Metz C., Stavitsky A.B., Bacher M., Bucala R. Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes. J Immunol 1998, 160(1):419-425.
56. Moore B.B., Murray L., Das A., Wilke C.A., Herrygers A.B., Toews G.B. The role of CCL12 in the recruitment of fibrocytes and lung fibrosis. Am J Respir Cell Mol Biol 2006, 35(2):175-181.
57. Lama V.N., Phan S.H. The extrapulmonary origin of fibroblasts: stem/progenitor cells and beyond. Proc Am Thorac Soc 2006, 3(4):373-376.
58. Sakai N., Wada T., Yokoyama H., Lipp M., Ueha S., Matsushima K., et al. Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci 2006, 103(38):14098-14103.
59. Masuda T., Tanaka H., Komai M., Nagao K., Ishizaki M., Kajiwara D., et al. Mast cells play a partial role in allergen-induced subepithelial fibrosis in a murine model of allergic asthma. Clin Exp Allergy 2003, 33(5):705-713.
60. Mori H., Kawada K., Zhang P., Uesugi Y., Sakamoto O., Koda A. Bleomycin-induced pulmonary fibrosis in genetically mast cell-deficient WBB6F1-W/Wv mice and mechanism of the suppressive effect of tranilast, an antiallergic drug inhibiting mediator release from mast cells, on fibrosis. Int Arch Allergy Appl Immunol 1991, 95(2-3):195-201.
61. Ayako S., Tohru T., Yukihisa F., Yasuo N., Nobuyuki T. Evaluation of role of mast cells in the development of liver fibrosis using mast cell-deficient rats and mice. J Hepatol 1999, 30(5):859-867.
62. Fairweather D., Frisancho-Kiss S., Yusung S.A., Barrett M.A., Davis S.E., Gatewood S.J.L., et al. Interferon-{gamma} protects against chronic viral myocarditis by reducing mast cell degranulation, fibrosis, and the profibrotic cytokines transforming frowth vactor-{beta}1, interleukin-1{beta}, and interleukin-4 in the heart. Am J Pathol 2004, 165(6):1883-1894.
63. Shiota N., Nishikori Y., Kakizoe E., Shimoura K., Niibayashi T., Shimbori C., et al. Pathophysiological role of skin mast cells in wound healing after scald injury: study with mast cell-deficient W/W(V) mice. Int Arch Allergy Immunol 2009, 151(1):80-88.
64. Fazel S., Cimini M., Chen L., Li S., Angoulvant D., Fedak P., et al. Cardioprotective c-kit+ cells are from the bone marrow and regulate the myocardial balance of angiogenic cytokines. J Clin Invest 2006, 116(7):1865-1877.
65. Kim J., Dadsetan M., Ameenuddin S., Windebank A.J., Yaszemski M.J., Lu L. In vivo biodegradation and biocompatibility of PEG/sebacic acid-based hydrogels using a cage implant system. J Biomed Mater Res A 2010, 95(1):191-197.
66. VandeVord P.J., Matthew H.W., DeSilva S.P., Mayton L., Wu B., Wooley P.H. Evaluation of the biocompatibility of a chitosan scaffold in mice. J Biomed Mater Res 2002, 59(3):585-590.
67. Metz C.N. Fibrocytes: a unique cell population implicated in wound healing. Cell Mol Life Sci 2003, 60(7):1342-1350.
68. Herzog E.L., Bucala R. Fibrocytes in health and disease. Exp Hematol 2010, 38(7):548-556.
69. Abe R., Donnelly S.C., Peng T., Bucala R., Metz C.N. Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. J Immunol 2001, 166(12):7556-7562.
70. Dy M., Schneider E. Histamine-cytokine connection in immunity and hematopoiesis. Cytokine Growth Factor Rev 2004, 15(5):393-410.
71. Ren S.R., Xu L.B., Wu Z.Y., Du J., Gao M.H., Qu C.F. Exogenous dendritic cell homing to draining lymph nodes can be boosted by mast cell degranulation. Cell Immunol 2010, 263(2):204-211.
72. Godot V., Arock M., Garcia G., Capel F., Flys C., Dy M., et al. H4 histamine receptor mediates optimal migration of mast cell precursors to CXCL12. J Allergy Clin Immunol 2007, 120(4):827-834.